BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+109.12%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$319M
AUM Growth
+$319M
(+88%)
Cap. Flow
+$50.2M
Cap. Flow
% of AUM
15.74%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
APTX
Aptinyx Inc. Common Stock
APTX
|
$53.8M |
Top Sells
| 1 |
InflaRx
IFRX
|
$3.56M |
Sector Composition
| 1 | Healthcare | 56.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $109M | 34.28% | 8,930,237 | – | – |
|
2
Solid Biosciences
SLDB
$427M
| $70.9M | 22.21% | 1,989,444 | – | – |
|
|
3
InflaRx
IFRX
$108M
| $57M | 17.85% | 1,766,038 -110,375 | -6% | -$3.56M |
|
|
APTX
4
DELISTED
Aptinyx Inc. Common Stock
APTX
| $53.8M | 16.85% | +2,225,092 | New | +$53.8M |
|
|
MRNS
5
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $28.1M | 8.81% | 3,977,453 | – | – |
|